JJDC finds transformative ideas and helps them mature into real solutions for today’s patients. As the strategic venture capital arm of the Johnson & Johnson Family of Companies, JJDC invests in early to late-stage biotechnology, healthcare, and medical sectors, with a focus on North America and Europe.
Deal activity and portfolio updates would appear here
Connect your data source to see recent transactions